×
返回 Agenda
Session 3 : COVID-19 Vaccine Development Strategy
Session Chair(s)
Jaeok Kim
Associate
Korean Food & Drug Administration, Korea, Republic of
Speaker(s)
James Baber, MPH
Pfizer, Australia
Director, Clinician/Global Medical Monitor
Yu Hwa Choi, MBA, RN
Quratis Inc., Korea, Republic of
Senior Managing Director, Head of Operations Division
Won Suk Choi, MD, PhD
Korea University Ansan Hospital , Korea, Republic of
Professor, Division of Infectious Diseases, Department of Internal Medicine
So Hee Kim, PhD
National Institute of Food and Drug Safety Evaluation (NIFDS), Korea, Republic of
Director / Ministry of Food and Drug Safety